Tenascin-C promotes healing of Habu-snake venom-induced glomerulonephritis: Studies in knockout congenic mice and in culture

American Journal of Pathology

Volumn 152, Issue 5, 1998, Pages 1237-1245

  Nakao, Naoyuki ^a,b   Hiraiwa, Noriko ^b   Yoshiki, Astushi ^b   Ike, Fumio ^b   Kusakabe, Moriaki ^b  

^a Internal Medicine   (Japan)

^b RIKEN TSUKUBA INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; SCLEROPROTEIN; SNAKE VENOM; TENASCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE DELETION; GLOMERULONEPHRITIS; GRANULATION TISSUE; KIDNEY FAILURE; MESANGIUM CELL; NEPHRITIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS;

ANIMALS; CELL COUNT; CELL DIVISION; CELLS, CULTURED; COLLAGEN; CROTALID VENOMS; CYTOKINES; DNA PRIMERS; FIBRONECTINS; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; REGENERATION; TENASCIN; TRIMERESURUS; WOUND HEALING;

EID: 0031953706     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Erickson HP: Tenascin-C, tenascin-R, and tenascin-X: a family of talented proteins in search of functions. Curr Opin Cell Biol 1993, 5:869-876
2. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Sakakura T: Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986, 47:131-139
3. Laywell ED, Dorries U, Bartsch U, Faissner A, Schachner M, Steindler DA: Enhanced expression of the developmentally regulated extracellular matrix molecule tenascin following adult brain injury. Proc Natl Acad Sci USA 1992, 89:2634-2638
4. Mackie EJ, Halfter W, Liverani D: Induction of tenascin in healing wounds. J Cell Biol 1988, 107:2757-2767
5. Saga Y, Yagi T, Ikawa Y, Sakakura T, Aizawa S: Mice develop normally without tenascin. Genes Dev 1992, 6:1821-1831
6. Steindler DA, Settles D, Erickson HP, Laywell ED, Yoshiki A, Faissner A, Kusakabe M: Tenascin knockout mice: barrels, boundary molecules, and glial scars. J Neurosci 1995, 15:1971-1983
7. Forsberg E, Hirsch E, Frohlich L, Meyer M, Ekblom P, Aszodi A, Werner S, Fassler R: Skin wounds and severed nerve heal normally in mice lacking tenascin-C. Proc Natl Acad Sci USA 1996, 93:6594-6599
8. Fukamauchi F, Malaga N, Wang YJ, Sato S, Yoshiki A, Kusakabe M: Abnormal behavior and neurotransmission of tenascin gene knockout mouse. Biochem Biophys Res Commun 1996, 221:151-156
9. Schlondorff D: The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB J 1987, 1:272-281
10. Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzi P, Gordon K, Cown AM: Expression of smooth muscular cell phenotype by rat mesangial cells in immune complex nephritis: alfa-smooth muscle actin in a marker of mesangial cell proliferation. J Clin Invest 1991, 87:847-858
11. Assad L, Schwartz MM, Virtanen I, Gould VE: Immunolocalization of tenascin and cellular fibronectins in diverse glomerulonephritis. Virchows Arch B Cell Pathol 1993, 63:307-316
12. Morita T, Churg J: Mesangiolysis. Kidney Int 1983, 24:1-9
13. Hiraiwa N, Kida H, Sakakura T, Kusakabe M: Induction of tenascin in cancer cells by interactions with embryonic mesenchyme mediated by a diffusible factor. J Cell Sci 1993, 104:289-296
14. Tsukamoto T, Kusakabe M, Saga Y: In situ hybridization with nonradioactive digoxigenin-11-UTP-labeled cRNA probes: localization of developmentally regulated mouse tenascin mRNAs. Int J Dev Biol 1991, 35:25-32
15. Johnson RJ, Raines EW, Floge J, Yoshimura A, Pritzl P, Alpers C, Ross R: Inhibition of mesangial cell proliferation and matrix expression in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 1992, 175:1413-1416
16. Border W, Noble, NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 1992, 360:361-364
17. Erickson HP: Gene knockouts of c-src, transforming growth factor-β1, and tenascin suggest superfluous, nonfunctional expression of proteins. J Cell Biol 1993, 120:1079-1081
18. Morita H, Maeda K, Obayashi M, Shinzato T, Nakayama A, Fujita Y, Kobayakawa H, Inoue I, Sugiyama S, Asai J, Nakashima I, Isobe, K: Induction of irreversible glomerulonephritis in the rat by repeated injections of a monoclonal anti-Thy-1.1 antibody. Nephron 1992, 60: 92-99
19. End P, Panayotou G, Entwistle A, Waterfield MD, Chiquet M: Tenascin: a modulator of cell growth. Eur J Biochem 1992, 209:1041-1051
20. Chung CY, Murphyullrich JE, Erickson HP: Mitogenesis, call migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptors, annexin II. Mol Biol Cell 1996, 7:883-892
21. Shrestha P, Sumitomo S, Lee CH, Nagahara K, Kamegai A, Yamanaka T, Takeuchi H, Kusakabe M, Mori M: Tenascin: growth and adhesion modulation-extracellular matrix degrading function: an in vitro study. Eur J Cancer B Oral Oncol 1996, 32B-2:106-113
22. Yayon A, Klagsbrun M, Esko JD, Ornitz DM: Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991, 64:841-848